LUCD vs OGN · rev $2.7M vs P/E 3.4, rev $3.02B
Lucid Diagnostics Inc (LUCD) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
Lucid Diagnostics Inc (LUCD) is a medical devices company listed on US.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported LUCD revenue for 2026-06-30 was $2.7M. Net income was -$25.6M. LUCD currently screens at market cap $123.3M.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
LUCD currently screens at market cap $123.3M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the LUCD and OGN stock pages for the full models.
Not investment advice.